The EUROTOX 2025 – European Congress of Toxicology ↗ will take place from 14 to 17 September 2025 in Athens, Greece. Recognized as Europe’s most prominent toxicology conference, EUROTOX gathers leading scientists, regulators, industry experts, and academics to explore the most pressing issues and innovations in toxicology. The scientific programme will emphasize emerging technologies, advanced methodologies, and interdisciplinary collaboration, with a focus on public health protection and environmental sustainability. EUROTOX 2025 provides a dynamic platform for knowledge exchange and aims to foster critical discussions that will shape the future of toxicological science: 

• Keynote lectures by renowned international experts
• Sessions on AI and computational toxicology, exposure science, omics technologies, and regulatory innovations
• Dedicated space for young researchers to present their work through oral and poster presentations
• Networking events promoting collaboration across sectors and disciplines 

The programme is designed to reflect the complexity of modern toxicology, addressing scientific, ethical, and regulatory challenges through multidisciplinary dialogue. 

PARC will have a significant presence at EUROTOX 2025, with contributions from researchers representing 12 institutions across 9 European countries. The collective participation of PARC teams underlines the initiative’s critical role in advancing toxicology and public health research at the European level. 

• Metabolic disruption of lipid metabolism in human liver cells presented by Neele Wewer (German Federal Institute for Risk Assessment ↗)
• Towards prospective identification of respiratory sensitizers: setting up a co-culture of bronchial epithelial and dendritic-like cells presented by Véronique de Bruijn (National Institute for Public Health and the Environment ↗, Netherlands)
• Involvement of glucocorticoid receptor in immunomodulation of THP-1 derived macrophages by bisphenol A substitutes presented by Nina Franko (Faculty of Pharmacy ↗, Slovenia)
• Implementation of NAMs in Pesticide Dossiers: Insights from PARC Project-PESTNAM presented by Emma Di Consiglio (Italian National Institute of Health ↗)
• Exploring Linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes presented by Elisavet Renieri
• A Next Generation PBK model for PFOA in humans presented by Chrysanthi Pachoulide (Wageningen University & Research ↗, Netherlands)
• The Genotoxic Potential of Emerging Bisphenol A Alternatives in an Advanced in vitro Zebrafish Hepatic Model presented by Alja Štern (National Institute of Biology ↗, Slovenia)
• Adverse (geno)toxic effects of BPA, its two analogues BPAP and BPC and their binary mixtures in in vitro 3D cell model presented by Martina  Štampar (National Institute of Biology ↗, Slovenia)
• Cell dialogue in disarray: unraveling non-genotoxic carcinogens through disrupted connexin-based communication presented by Pavel Babica (RECETOX ↗, Czechia)
• Mechanistic Insights of BPA Alternatives on PPARγ Binding and Consequences on Adipocyte Differentiation presented by Daniela Flores Gomez (Utrecht University ↗, Netherlands)
• Cadmium in the Portuguese Diet: A Food Sustainability Perspective on Human Exposure from Plant- and Animal-Based Foods  presented by Sónia Namorado (Portuguese National Institute of Health Dr. Ricardo Jorge, Portugal) ↗
• Prenatal mercury exposure and the associated risk: a call for preventive action based on Human Biomonitoring Data from Portuguese Pregnant Women presented by Sónia Namorado (Portuguese National Institute of Health Dr. Ricardo Jorge, Portugal)  ↗
• Establishment of Readiness Criteria for AI-based tools for risk assessment: READYAI presented by Joyce de Paula Souza (University of Basel ↗, Switzerland)
• Assessment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Louise Gütter (National Research Institute for Agriculture, Food and Environment ↗, France)
• Biotransformation of the colour developer Pergafast 201 in human in vitro models presented by Daniel Zalko (National Research Institute for Agriculture, Food and Environment ↗, France)
• How advancements in OECD genotoxicity TGs improve chemical safety assessments and challenge retrospective data analysis for NAM based IATA development presented by Vasiliki Hatzi (Benaki Phytopathological Institute ↗, Greece)
• Creation of a FAIR data policy for the Partnership for the Assessment of Risk from Chemicals (PARC). Exploring LLMs and data sciences for identification of future topics and stakeholder interests presented by Rob Stierum (Netherlands Organization for Applied Scientific Research ↗)
• Use of New Approach Methodologies (NAMs) in unravelling interspecies Toxicokinetics of Enniatin B1 presented by Mariam Mahdjoub (French Agency for Food, Environmental and Occupational Health & Safety ↗)
• The PARC Real-life Mixtures Project: Mixture Risk Assessment Results of the Case Studies on Pesticides, PFAS and Heavy Metals presented by Hannah McKeon (National Institute for Public Health and the Environment ↗, Netherlands)
• Assessment of the Metabolic Fate of Bisphenol A Alternatives Prioritized Under the PARC Project in HepaRG cells presented by Daniel Zalko (National Research Institute for Agriculture, Food and Environment ↗, France)
• Neuroendocrine changes and oxidative stress following PFAS exposure using the Zebrafish (Danio rerio) model  presented by Sarah Elise Smebakk Nilsen (Norwegian University of Life Sciences ↗)
• Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring data  presented by Noelia Domínguez-Morueco (Carlos III Health Institute ↗, Spain)
• Human Choroid Plexus Organoid Model to Test Inhibition of Thyroid Hormone Transport across the Blood-Cerebrospinal fluid-Barrier presented by Kim Heikamp (Vrije Universiteit Amsterdam ↗, Netherlands)
• Mycotoxins from the Alternaria fungi sp. may modulate the activation of the toll like receptor – NFkB-signalling pathway  presented by Solveig Krapf (National Institute of Occupational Health ↗, Norway)
• Advancing immunotoxicology with animal-free models: a novel approach for TD and TI antibody response assays presented by Martina Martina Iulini (Università degli Studi di Milano ↗, Italy)
• WP3: PARC ambition for synergies and communication to gain impact presented by Aglaia Koutsodimou (Independent Authority of Public Revenue ↗, Greece)
• Comparison of aggregate exposure to PFAS from diet and environment sources with Spanish human biomonitoring data  presented by Domínguez-Morueco Noelia  (Carlos III Health Institute ↗, Spain)
• Ensuring protocol robustness and integrity in the development of Adverse Outcome Pathway (AOP) for regulatory application presented by Barbara Viviani  (Università degli Studi di Milano ↗, Italy)

EUROTOX 2025 is a cornerstone event for professionals engaged in toxicology and chemical risk assessment. We warmly invite all stakeholders, scientists, and policymakers to join this prestigious congress in Athens. Engage in leading-edge discussions, discover new collaborations, and contribute to shaping the future of toxicology.